Skip to main content
PRAX logo

PRAX · Praxis Precision Medicines, Inc. · Executive Compensation

Track PRAX — free
$310.90 +5.71 (+1.87%) At close · Nov 19 Play latest call Q2 2026 earnings call transcript
Market Cap
$8.69B
Shares
27.95M
Volume · Nov 19 634.76K Avg daily vol (3M) 474.51K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Marcio Souza $8,708,648
Timothy Kelly $3,201,194
Alex Nemiroff $2,843,783
Fiscal 2024
Executive Total
Marcio Souza $13,427,668
Timothy Kelly $4,044,861
Alex Nemiroff $3,918,084
Fiscal 2023
Executive Total
Marcio Souza $2,120,512
Timothy Kelly $1,023,800
Alex Nemiroff $843,105
Fiscal 2022
Executive Total
Marcio Souza $6,028,078
Bernard Ravina $2,763,754
Timothy Kelly $2,303,213
Nicole Sweeny $2,283,756
Fiscal 2021
Executive Total
Marcio Souza $10,905,820
Bernard Ravina $4,509,171
Nicole Sweeny $3,727,856
Fiscal 2020
Executive Total
Marcio Souza $11,741,959
Bernard Ravina $1,711,010
Nicole Sweeny $1,654,052
Stuart Chaffee $1,647,683
Kiran Reddy $149,242
Fiscal 2019
Executive Total
Kiran Reddy $576,592
Bernard Ravina $551,271
Stuart Chaffee $391,775

Executive changes

Person Change Filed
Stuart A. Arbuckle Appointed 2026-01-08
Jeffrey B. Kindler Appointed 2026-01-08
Megan Sniecinski Appointed 2026-01-08
Jill DeSimone Already on the board
Since at least 2022: re-election or new board role
2024-06-06
Dean Mitchell Already on the board
Since at least 2020: re-election or new board role
2024-06-06
Stefan Vitorovic
“Mr. Vitorovic's decision to resign was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the operations, policies or practices of the Company.”
Resigned 2022-08-12
Bernard Ravina Resigned 2022-07-26
Jill DeSimone Appointed 2022-05-23

Leadership

Key facts CIK 1689548 CUSIP 74006W207 13F (30d) 361 filings 331 filers Visit website Investor relations